Research Fellow

Maëva Chauvin joined the Pépin Laboratory in 2020 after completing her PhD at the Institut de Recherche en Cancérologie (Cancer Research Institute) in Montpellier, France where she studied the the role of anti-Müllerian hormone and its receptors in gynecological cancers and developed therapeutic antibodies. She is currently studying how the AMH/AMHR2 pathway may regulate the tumor microenvironment in ovarian cancer.

Project: “Therapeutic strategies targeting the AMH/AMHR2 axis to modulate the ovarian tumor microenvironment” (Department of Defense Ovarian Cancer Academy).